scholarly journals Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial

2014 ◽  
Vol 10 (2) ◽  
pp. 204-211 ◽  
Author(s):  
Victor Legrand ◽  
Thomas Cuisset ◽  
Patrick Chenu ◽  
Mathy Vrolix ◽  
Christophe Martinez ◽  
...  
Keyword(s):  
Coronary Artery Disease ◽  
Percutaneous Coronary Intervention ◽  
Coronary Artery ◽  
Stent Thrombosis ◽  
Cardiovascular Events ◽  
Platelet Reactivity ◽  
Stable Coronary Artery Disease ◽  
Coronary Intervention ◽  
Percutaneous Coronary ◽  
Artery Disease

scholarly journals Peripheral Artery Disease on The Prognosis Value of Patients with Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Retrospective, Single-Center Cohort Study

2021 ◽  
Vol 24 (5) ◽  
pp. E887-E892
Author(s):  
Zeyi Cheng ◽  
Miaomiao Qi ◽  
Zekun Lang ◽  
Tingting Fang ◽  
Mahboob Alam ◽  
...  
Keyword(s):  
Coronary Artery Disease ◽  
Percutaneous Coronary Intervention ◽  
Coronary Artery ◽  
Cardiovascular Events ◽  
Stable Coronary Artery Disease ◽  
Coronary Intervention ◽  
Peripheral Artery ◽  
Percutaneous Coronary ◽  
Artery Disease ◽  
Stable Cad

Objective: The purpose of this investigation aimed to clarify the impact of peripheral artery disease (PAD) on the prognosis value of patients with stable coronary artery disease (CAD) who underwent percutaneous coronary intervention (PCI). Methods: The SPSS 16 software was used for secondary analysis of DRYAD database data. A total of 204 patients were enrolled from Shinonoi General Hospital for newly diagnosed stable CAD and received PCI performance between October 2014 and October 2017. Patients with old myocardial infarction (MI) were excluded. We divided patients into two groups with PAD and without PAD. The primary endpoints were major adverse cardiac events (MACE, defined as all-cause death, non-fatal MI, and non-fatal stroke) and cardiovascular events (defined as cardiovascular death, non-fatal MI, and non-fatal stroke). The secondary outcomes were the individual components of the composite primary outcomes. The median follow-up time was 783 days. Results: No statistical difference was found between PAD and non-PAD patients of lesional characteristics. Spearman’s rank correlations indicate diabetes mellitus (DM) (P = 0.019) and HbA1c (P = 0.009) are positively correlated with PAD. In Kaplan-Meier analysis, patients with PAD predicted poor prognosis in MACE (P < 0.05) and cardiovascular events (P < 0.05). In Multivariable Cox proportional hazards analysis, patients with PAD independently predicted MACE and cardiovascular events. Conclusions: PAD is a significant mediator for the prognosis of patients with stable CAD who underwent PCI treatment.

Sign in / Sign up

Export Citation Format

Share Document